Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carboplatin × Other neoplasm × Clear all

Phase

Phase 2 2 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 18 Gynecologic 8 Breast 8 Genitourinary 4 Head & Neck 3 CNS 2 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1 Classical hematology 1

Conditions

Primary Malignant Neoplasm of Ovary 1

Interventions

Decitabine 4 Busulfan 3 Cyclophosphamide 2 venetoclax 1 fludarabine 1 Paclitaxel 1 Influenza Vaccines 1 Celecoxib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02159820 2014-06-10

DAC and CT

Chinese PLA General Hospital

Phase 2/3 Unknown

Primary Malignant Neoplasm of Ovary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡